immune responses
[대역어] 면역 반응
[용어속성] Action
[용어속성] Action
Long Term Immune Response Produced by the SputnikV Vaccine
스푸트니크 V 백신에 의해 생성된 장기 면역 반응
Article
Published on
Journal: International Journal of Molecular Sciences [Category] MERS, SARS, 변종, 유전자 메커니즘,
Journal: International Journal of Molecular Sciences [Category] MERS, SARS, 변종, 유전자 메커니즘,
[키워드] Activation
analyzed
antibody
breadth
cellular immune responses
cellular immunity
circulating variant
circulating variants
conserved
conserved regions
convalescent COVID-19 patient
convalescent sera
convalescent serum
cytokine
Cytokines
domain
evidenced
first dose
fusion
fusion protein
high potency
HRs
humoral
humoral immune response
immune responses
immunized
immunogenic
induce
location
Long
mechanism
Microbiology
N-terminal
N-terminal domain
NTD
overlapping
peptide
peptides
RBD
reactivity
Receptor binding domain
Region
Repeat
response
S protein
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 S protein
serum
shown
Spike protein
SputnikV
T cells
term
the SARS-CoV-2
the vaccine
vaccinated individual
Vaccine
[DOI] 10.3390/ijms222011211 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms222011211 PMC 바로가기 [Article Type] Article
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
Review
[키워드] Abstract
ACE-2, Angiotensin-converting enzyme 2
AKI, acute kidney injury
Ang II, Angiotensin II
BALF, Broncho alveolar lavage fluid
cGMP, Good Manufacturing Practice
Characteristics
coronavirus disease 19
COVID-19
COVID-19 infection
COVID-19, Coronavirus disease of 2019
CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats
CRS, Cytokine release syndrome
CT, Computed tomography
CT, Cycle threshold
current
Cytokine storm
DENV, dengue virus
develop
diagnostic tests
dimension
drugs
emerging variants
FDA, Food and Drug Administration
FNR, False‐negative rate
Genome
GGOs, Ground-glass opacities
global effort
HAT, Human airway trypsin-like protease
health emergency
Health Organization
HIV, Human immunodeficiency virus
IBV, infectious bronchitis virus
ICU, Intensive care unit
IL, interleukin
immune response
immune responses
Immunity
include
Infection
International
JEV, Japanese encephalitis virus
lack
LAMP, Loop-mediated isothermal amplification
LF, Lactoferrin
mechanism
MIP1α, Macrophage inflammatory protein 1α
MRI, Magnetic resonance imaging
MSC, Mesenchymal Stem Cells
Mutation
mutations
NCD, Newcastle disease virus
new virus
NP, nasopharyngeal
NSPs, Nonstructural proteins
OP, Oropharyngeal
pandemic
Pathogenesis
pathogenicity
Potential treatment
Prevent
problem
RAS, Renin-angiotensin system
RBD, Receptor binding-domain
RdRp, RNA-dependent RNA polymerases
Reinfection
Research
resulting
SARS-CoV
SARS-CoV-2
SARS-COV-2, severe acute respiratory syndrome coronavirus-2
severity
TGF, Transforming growth factor
Th17, T helper 17
the disease
the SARS-CoV-2
therapeutic
therapy
Transmissibility
treat
Vaccine
vaccine candidate
Vaccine development
Vaccines
variant
variants
variants of SARS-CoV-2
virus
VLPs, Virus-like particles
VTM, Viral transport medium
while
WHO
WNV, West Nile virus
[DOI] 10.1016/j.intimp.2021.108232 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.intimp.2021.108232 PMC 바로가기 [Article Type] Review
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects
SARS-CoV-2 특정 기억 T 세포 에피토프가 COVID-19 회복 대상에서 확인됨
Article
[키워드] Activation
Analysis
B cell
caused
CD4
CD8 T cell
Cell
Coronaviral
COVID-19
COVID-19 pandemic
COVID-19 vaccine design
defined
ELISPOT
enzyme
enzyme-linked immunosorbent
epitope
epitope mapping
Epitopes
evaluated
examined
explicit
flow cytometry
followed by
foundation
glycoprotein
HLA
Hope
host immunity
IgG
immune
immune responses
immunodominant epitopes
immunogenic
immunogenicity
in some
individual
induce
mapped
memory T
memory T cells
mononuclear cell
N protein
neutralizing antibody
Neutralizing antibody response
neutralizing antibody responses
nucleocapsid
nucleoprotein
Outbreaks
PBMCs
peptide
peptides
Peripheral blood
Peripheral blood mononuclear cells
positively correlated
proportion
protective immunity
Protein
public health
RBD
receptor
Receptor-binding domain
Reinfection
response
robust
S protein
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 S
spike
spike glycoprotein
stimulate
structural proteins
subject
subjects
T cell
T cell activation
T cell epitope
T cell epitopes
T cell response
T cell responses
T cells
the receptor-binding domain
the S protein
Therapeutics
vaccination
Vaccine
Vaccine design
virus-specific T cell
virus-specific T cell responses
were used
[DOI] 10.1016/j.virusres.2021.198508 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.virusres.2021.198508 PMC 바로가기 [Article Type] Article
Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer
Review
[키워드] Administered
alphavirus
animal models
applied
approval
approved
Brain
Cancer
Cell
clinical
clinical settings
cytoplasm
development
DNA
dose
Ebola virus
Ebola virus disease
evaluated
expression levels
extreme
Hepatitis B virus
HIV
immune response
immune responses
Infectious disease
Infectious diseases
Influenza virus
lung
Melanoma
mRNA
ovarian
Particles
pathogen
plasmids
Prostate cancer
protection
protein expression
replicate
RNA
RNA vaccine
RNA viruses
RNA-dependent RNA polymerase
robust
SARS-CoV-2 vaccine
self-replicating RNA viruses
shown
significantly lower
Single-stranded RNA viruses
surface protein
transgene
translation
Trial
tumor antigen
tumor regression
Vaccine
Vaccine development
Vaccines
Viral vector
virus
[DOI] 10.3390/vaccines9101187 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/vaccines9101187 PMC 바로가기 [Article Type] Review
The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children
소아에서 과염증성 다기관 염증 증후군의 자가면역 시그니처
Article
[키워드] Admission
Analysis
anti-Spike IgG
antigenic
antigens
autoantibodies
autoantibody
autoantigen
Autoimmune
Autoimmune diseases
Autoimmunity
B cell
BCR
Cellular immune response
children
Cluster
Coagulation
coagulation pathways
Combination
complement
contributing to
COVID-19
Cytokines
expressed
Factor
Genes
heavy chain
humoral immune responses
Hyperinflammatory
identify
IgG
IGHV
immune
immune responses
Immunoglobulin
Immunopathogenesis
Inflammation
inflammation markers
Inflammatory
Inflammatory response
intensive care
intensive care unit admission
manifestation
Mild
MIS-C
Multiorgan
neutrophil
neutrophil activation
neutrophil response
pathogenic
pathway
Patient
Previous studies
previous study
proteomics
receptor
RNA sequencing
SARS-COV-2 infection
sequence
Sequencing
serum
superantigen
syndrome
T cell
T cell receptor
TCR
tissue damage
TRBV11-2
Treatment
Usage
variable region
[DOI] 10.1172/JCI151520 PMC 바로가기 [Article Type] Article
[DOI] 10.1172/JCI151520 PMC 바로가기 [Article Type] Article
Cytidine deamination-induced perpetual immunity to SAR-CoV-2 infection is a potential new therapeutic target
SAR-CoV-2 감염에 대한 시티딘 탈아미노화 유도 영구 면역은 잠재적인 새로운 치료 표적입니다
Review
[키워드] antibody
Asymptomatic
cause
causes
cell types
contributing to
COVID 19
COVID-19
cytidine
Cytidine deaminase
develop
focus
generate
Human
immune cell type
immune cell types
immune response
immune responses
immune system
Immunity
Infection
initiate
long-lasting
molecular
New variants of Coronavirus
Perpetual immunity
provided
reason
Research
responses
SAR-CoV-2
SARS-CoV-2
SARS-CoV-2 virus
SRS-CoV-2
Survivors
symptomatic people
the SARS-CoV-2 virus
therapeutic target
vaccination
Variation
variations
viral strains
virus
[DOI] 10.7150/ijms.61779 PMC 바로가기 [Article Type] Review
[DOI] 10.7150/ijms.61779 PMC 바로가기 [Article Type] Review
An Update on Innate Immune Responses during SARS-CoV-2 Infection
SARS-COV-2 감염 동안 타고난 면역 반응에 대한 업데이트
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Antiviral
cellular receptor
cellular receptors
characterized
components
Coronaviridae family
coronavirus
COVID-19 pandemic
Cytokines
Defense
disrupt
Effect
followed by
Host
hypersecretion
IFN-α/β
IFNs
immune dysfunction
immune responses
Innate
innate immune
innate immune response
innate immune responses
innate immune system
interferons
invading pathogen
invading pathogens
member
Mortality
organ injury
Pathogens
patients with COVID-19
potential therapeutic targets
pro-inflammatory cytokines
protease
respiratory
response
responses
responsible
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
Signaling
the Coronaviridae
Type I IFN
type I interferon
type I interferons
variety
Viral
[DOI] 10.3390/v13102060 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/v13102060 PMC 바로가기 [Article Type] Review
SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment
RNAi에 의한 SARS-CoV-2 표적화 및 숙주 보체 억제: COVID-19 치료를 위한 두 갈래의 속임수
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
approach
C3a
clinical manifestation
clinical manifestations
complement
Complement inhibitor
component
conjunction
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID‐19
COVID‐19 patients
curtail
cytokine
Cytokine storm
degrade
detrimental
Disease progression
disease progression and severity
downstream
effective
Evidence
exacerbate
gene regulation processes
globe
Host
immune responses
infections
information
inhibitor
knowledge
lack
less
Local
mitigate
molecules
ORF
Perspective
preventive measure
preventive measures
progression
Proinflammatory cytokine
protective immunity
Replication
required
respiratory
Result
RNA interference
RNAi
robust
SARS‐CoV‐2
severe acute respiratory syndrome Coronavirus
severity
Spread
suppress
symptomatic and asymptomatic
systemic immune response
systemic immune responses
the cytokine storm
transcript
transmissible variant
Treatment
vaccinate
Vaccine
variants
Viral
viral spread
viral/retroviral
virus
[DOI] 10.1002/iid3.549 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/iid3.549 PMC 바로가기 [Article Type] Review
SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro
SARS – COV – 2 스파이크는 DNA 손상 복구를 손상시키고 V (D) J J 재조합을 억제합니다.
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
adaptive
Adaptive immunity
affecting
BRCA1
cell line
clinical
Clinical outcome
clinical outcomes
Clinical studies
coronavirus
coronavirus disease
Coronavirus disease 2019
damage
DNA
DNA damage
DNA damage repair
DNA repair
effective
full-length
immune
immune responses
Immunity
impede
in vitro
indicated
Infection
influence
inhibit
mechanism
nucleus
pandemic
Patient
patients
potential molecular
Protein
public health
Recombination
recruitment
repair
required
respiratory
SARS–CoV–2
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
Side effect
significantly
spike
Spike protein
spike-based vaccines
the spike protein
V(D)J recombination
Vaccine
[DOI] 10.3390/v13102056 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v13102056 PMC 바로가기 [Article Type] Article